Article info
Original article
Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer
- Correspondence to Professor Alexandar Tzankov, Department of Pathology, University Hospital Basel, Schoenbeinstrasse 40, Basel CH-4031, Switzerland; alexandar.tzankov{at}usb.ch
Citation
Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer
Publication history
- Received December 10, 2014
- Revised February 2, 2015
- Accepted February 3, 2015
- First published March 2, 2015.
Online issue publication
August 11, 2020
Article Versions
- Previous version (11 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions